• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

电话管理多发性硬化行走量表 12 评分在多发性硬化症患者中的验证。

Validation of scores from a telephone administered multiple sclerosis walking scale-12 in persons with multiple sclerosis.

机构信息

Department of Kinesiology and Nutrition, University of Illinois at Chicago, 1919 West Taylor St, Applied Health Sciences Building, Room 506J, Chicago IL, 60612, United States.

Department of Physical Therapy, MGH Institute of Health Professions, United States.

出版信息

Mult Scler Relat Disord. 2024 Aug;88:105715. doi: 10.1016/j.msard.2024.105715. Epub 2024 Jun 9.

DOI:10.1016/j.msard.2024.105715
PMID:38889558
Abstract

BACKGROUND

The Multiple Sclerosis Walking Scale-12 (MSWS-12) has typically been delivered through paper-and-pencil or computer-based administration.

PURPOSE

This study examined the validity of inferences from scores derived via a telephone administration of the MSWS-12 applied as part of screening of participants with walking dysfunction into a clinical trial of exercise training in MS.

METHOD

The MSWS-12 was administered on two occasions separated by approximately 2 weeks through the telephone and then in-person (i.e., computer-based administration). Participants further completed the Patient Determined Disease Steps (PDDS) scale, timed 25-foot walk (T25FW), six-minute walk (6MW), Modified Fatigue Impact Scale (MFIS), and Multiple Sclerosis Impact Scale-29 (MSIS-29), and underwent a neurological exam for generating an expanded disability status scale (EDSS) score. The primary set of data (Full Sample) for analyses included all persons who passed the telephone screening for inclusion with MSWS-12 scores between 25 and 75 (N = 374). The secondary set of data (Truncated Sample) included only persons with MSWS-12 scores between 25 and 75 for both the telephone and computer administrations of the MSWS-12 (N = 248).

RESULTS

The results in the Full Sample indicated a difference in overall and item levels scores between the telephone and computer data collections, and the computer version had higher internal consistency and stronger unidimensionality. Nevertheless, MSWS-12 scores from both modes of administration had comparable correlations with the T25FW, 6MW, EDSS, PDDS, MFIS, and MSIS-29, but the correlation between the two MSWS-12 administrations did not approach unity. There was a systematic difference in scores between telephone and computer administrations across levels of walking dysfunction based on a Bland-Altman plot, and the difference was predicted by MFIS physical, 6MW, and EDSS scores. The comparison of results between the Full and Truncated Samples suggested that the primary analysis might have been influenced by the larger range of scores on the computer than telephone administrations of the MSWS-12.

CONCLUSION

The telephone administration of the MSWS-12 provides an efficient and cost-effective measure of walking dysfunction in persons with MS.

摘要

背景

多发性硬化症步行量表-12(MSWS-12)通常通过纸质或基于计算机的方式进行管理。

目的

本研究通过电话管理 MSWS-12 来评估从电话管理 MSWS-12 中获得的分数推断的有效性,该管理方法应用于因行走功能障碍而参加运动训练临床试验的参与者的筛选。

方法

通过电话在大约 2 周内两次管理 MSWS-12,然后亲自(即基于计算机的管理)管理。参与者还完成了患者确定疾病步骤(PDDS)量表、25 英尺步行计时(T25FW)、6 分钟步行(6MW)、改良疲劳影响量表(MFIS)和多发性硬化症影响量表-29(MSIS-29),并进行了神经检查以生成扩展残疾状态量表(EDSS)评分。用于分析的主要数据集(完整样本)包括通过电话筛选并通过 MSWS-12 评分在 25 到 75 之间的所有人员(N=374)。辅助数据集(截断样本)仅包括电话和计算机管理 MSWS-12 评分均在 25 到 75 之间的人员(N=248)。

结果

在完整样本中,电话和计算机数据收集的总体和项目水平得分存在差异,计算机版本的内部一致性更高,单维性更强。尽管如此,两种模式管理的 MSWS-12 评分与 T25FW、6MW、EDSS、PDDS、MFIS 和 MSIS-29 的相关性相当,但两种 MSWS-12 管理之间的相关性并未接近统一。根据 Bland-Altman 图,在基于行走障碍程度的得分中,电话和计算机管理之间存在系统差异,并且差异可以通过 MFIS 物理、6MW 和 EDSS 分数预测。完整和截断样本之间结果的比较表明,主要分析可能受到 MSWS-12 计算机管理与电话管理之间更大范围分数的影响。

结论

MSWS-12 的电话管理为多发性硬化症患者的行走功能障碍提供了一种高效、经济有效的测量方法。

相似文献

1
Validation of scores from a telephone administered multiple sclerosis walking scale-12 in persons with multiple sclerosis.电话管理多发性硬化行走量表 12 评分在多发性硬化症患者中的验证。
Mult Scler Relat Disord. 2024 Aug;88:105715. doi: 10.1016/j.msard.2024.105715. Epub 2024 Jun 9.
2
Middle-range scores from the patient determined disease steps scale reflect varying levels of walking dysfunction in multiple sclerosis.从中程评分来看,患者确定疾病步骤量表反映了多发性硬化症患者在行走功能障碍方面存在不同程度的差异。
BMC Neurol. 2024 Oct 10;24(1):383. doi: 10.1186/s12883-024-03871-1.
3
Japanese translation and validation of the 12-item Multiple Sclerosis Walking Scale version 2.12 项多发性硬化症步行量表第 2 版的日译及验证。
Mult Scler Relat Disord. 2024 Sep;89:105768. doi: 10.1016/j.msard.2024.105768. Epub 2024 Jul 11.
4
Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.认知加工速度对多发性硬化症步行量表 12 评分的结构效度影响很小。
J Neurol Sci. 2013 Dec 15;335(1-2):169-73. doi: 10.1016/j.jns.2013.09.024. Epub 2013 Sep 24.
5
Do depressive and anxiety symptoms influence the construct validity of Multiple Sclerosis Walking Scale-12 scores?抑郁和焦虑症状是否影响多发性硬化症行走量表-12 评分的结构效度?
Rehabil Psychol. 2024 May;69(2):129-134. doi: 10.1037/rep0000534. Epub 2024 Jan 1.
6
Accelerometry as a measure of walking behavior in multiple sclerosis.加速度计作为多发性硬化症行走行为的测量手段。
Acta Neurol Scand. 2013 Jun;127(6):384-90. doi: 10.1111/ane.12036. Epub 2012 Dec 13.
7
Results of a feasibility and initial efficacy clinical trial of a high-intensity interval training program using adaptive equipment in persons with multiple sclerosis who have walking disability.使用自适应设备对有行走障碍的多发性硬化症患者进行高强度间歇训练方案的可行性和初步疗效的临床研究结果。
Mult Scler Relat Disord. 2024 Jul;87:105695. doi: 10.1016/j.msard.2024.105695. Epub 2024 May 24.
8
Validation of the Brazilian version of the patient-determined disease steps scale in persons with multiple sclerosis.验证多发性硬化症患者使用的患者确定疾病步骤量表的巴西版本。
Mult Scler Relat Disord. 2019 May;30:208-214. doi: 10.1016/j.msard.2019.02.022. Epub 2019 Feb 22.
9
Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12).多发性硬化步行量表12项(MSWS - 12)有效性的确认与扩展
J Neurol Sci. 2008 May 15;268(1-2):69-73. doi: 10.1016/j.jns.2007.11.003. Epub 2007 Dec 3.
10
Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis.多发性硬化症患者自我确定疾病阶段(PDDS)量表评分的验证
BMC Neurol. 2013 Apr 25;13:37. doi: 10.1186/1471-2377-13-37.